Leaders in Ion Channel Biology
Leaders in Ion Channel Biology
Welcome to Metrion Biosciences
Metrion Biosciences is a UK-based Contract Research Organization (CRO) focussed on delivering a range of high quality ion channel drug discovery services. We provide highly skilled electrophysiology screening services to support client medicinal chemistry optimisation programmes, CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays. Working closely with our collaborators Assay.Works and Concept Life Sciences we also offer an expert integrated drug discovery service.
Metrion offers flexible business models according to the scope of each programme, with both fee-for-service and collaborative options available.
Our Expertise
Metrion has assembled a team of highly expert and dedicated ion channel specialists to support diverse ion channel drug discovery projects and modern safety assessment research. We combine in depth target class knowledge and high quality screening assays with experienced and collaborative project managers to keep your research focused upon meeting both objectives and timelines.
Our Facilities
Metrion is located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities for native and engineered cell line and induced pluripotent stem cell culture, a comprehensive suite of automated patch clamp platforms, multiple manual patch clamp rigs, fluorescence-based screening capability and laboratory data management and reporting systems.
Latest News
Metrion and Venomtech collaborate to serach for novel ion channel modulators
Metrion announce collaboration to search for novel modulators of ion channels with proven therapeutic potential. The full press release can [...]
Drug Discovery News article: Double the drug discovery options
Metrion's collaboration with Assay.Works featured in the April 2017 edition of Drug Discovery News. The article can be found here. [...]
Q1 2017 review
Metrion Biosciences' review of Q1 2017 can be found here.